TY  - GEN
AU  - Nevill,T J
AU  - Hogge,D E
AU  - Toze,C L
AU  - Nantel,S H
AU  - Power,M M
AU  - Abou Mourad,Y R
AU  - Song,K W
AU  - Lavoie,J C
AU  - Forrest,D L
AU  - Barnett,M J
AU  - Shepherd,J D
AU  - Nitta,J Y
AU  - Wong,S
AU  - Sutherland,H J
AU  - Smith,C A
TI  - Predictors of outcome following myeloablative allo-SCT for therapy-related myelodysplastic syndrome and AML
SN  - 1476-5365
PY  - 2009///0107
KW  - Adult
KW  - Alkylating Agents
KW  - adverse effects
KW  - Enzyme Inhibitors
KW  - Female
KW  - Hematopoietic Stem Cell Transplantation
KW  - mortality
KW  - Humans
KW  - Leukemia, Myeloid, Acute
KW  - etiology
KW  - Male
KW  - Middle Aged
KW  - Myeloablative Agonists
KW  - Myelodysplastic Syndromes
KW  - Neoplasms, Second Primary
KW  - therapy
KW  - Prognosis
KW  - Radiotherapy
KW  - Retrospective Studies
KW  - Risk Factors
KW  - Survival Analysis
KW  - Topoisomerase II Inhibitors
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1038/bmt.2008.226
ER  -